METHODS AND COMPOUNDS FOR ANTIMICROBIAL INTERVENTION
    1.
    发明申请
    METHODS AND COMPOUNDS FOR ANTIMICROBIAL INTERVENTION 有权
    抗微生物干预的方法和化合物

    公开(公告)号:US20120046282A1

    公开(公告)日:2012-02-23

    申请号:US12997429

    申请日:2009-06-05

    CPC分类号: C07D487/04

    摘要: The present invention provides Wall Teichoic Acid biosynthesis inhibitors such as compound 1835F03 (targocil) and related synthetic analogs. The invention also provides pharmaceutical compositions thereof and methods for treating bacterial infection and the suppression of growth of bacterial cells by administering a Wall Teichoic Acid biosynthesis inhibitor. The invention is particularly useful for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA). The invention further provides procedures for the syntheses of Wall Teichoic Acid biosynthesis inhibitors. The invention also provides methods for the identification of antibacterial therapeutic agents.

    摘要翻译: 本发明提供了墙壁磷酸生物合成抑制剂,例如化合物1835F03(targocil)和相关的合成类似物。 本发明还提供了其药物组合物和通过施用壁壁磷酸生物合成抑制剂来治疗细菌感染和抑制细菌细胞生长的方法。 本发明特别可用于治疗耐甲氧西林金黄色葡萄球菌(MRSA)。 本发明还提供了合成壁磷酸生物合成抑制剂的方法。 本发明还提供了用于鉴定抗菌治疗剂的方法。

    Methods and compounds for antimicrobial intervention
    2.
    发明授权
    Methods and compounds for antimicrobial intervention 有权
    抗微生物干预的方法和化合物

    公开(公告)号:US08598342B2

    公开(公告)日:2013-12-03

    申请号:US12997429

    申请日:2009-06-05

    CPC分类号: C07D487/04

    摘要: The present invention provides Wall Teichoic Acid biosynthesis inhibitors such as compound 1835F03 (targocil) and related synthetic analogs. The invention also provides pharmaceutical compositions thereof and methods for treating bacterial infection and the suppression of growth of bacterial cells by administering a Wall Teichoic Acid biosynthesis inhibitor. The invention is particularly useful for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA). The invention further provides procedures for the syntheses of Wall Teichoic Acid biosynthesis inhibitors. The invention also provides methods for the identification of antibacterial therapeutic agents.

    摘要翻译: 本发明提供了墙壁磷酸生物合成抑制剂,例如化合物1835F03(targocil)和相关的合成类似物。 本发明还提供了其药物组合物和通过施用壁壁磷酸生物合成抑制剂来治疗细菌感染和抑制细菌细胞生长的方法。 本发明特别可用于治疗耐甲氧西林金黄色葡萄球菌(MRSA)。 本发明还提供了合成壁磷酸生物合成抑制剂的方法。 本发明还提供了用于鉴定抗菌治疗剂的方法。